Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2021
- The Future of Generics
Advertise

Search

Search

Close

Trending

US Democrats’ blockbuster budget bill could spell big changes for drug prices

Sosei Heptares banks $30m milestone in Neurocrine Bio alliance

Bayer tops pharma rankings for diversity, inclusivity

Sanofi looks east with €300m Innovent cancer alliance

Traditional approaches to growth in biopharma are no longer sustainable

BioSig Technologies

SARS-CoV-2

News/ News/ R&D

BioSig abandons COVID-19 drug trial on safety concerns

Phil Taylor antiviral, BioSig Technologies, coronavirus, COVID-19, Gilead Sciences, Veklury 0 Comment

US biotech BioSig Technologies has abandoned a phase 2 trial of its antiviral drug merimepodib with Gilead’s Veklury

X

BioSig abandons COVID-19 drug trial on safety concerns

https://pharmaphorum.com/news/biosig-abandons-covid-19-drug-trial-on-safety-concerns/

Coronavirus positive

News/ News/ R&D

Biosig cleared to test merimepodib plus remdesivir in COVID-19

Phil Taylor BioSig Technologies, clinical trial, coronavirus, ViralClear 0 Comment

US biotech BioSig Technologies’ subsidiary ViralClear has been cleared by the FDA to start a phase 2 trial

X

Biosig cleared to test merimepodib plus remdesivir in COVID-19

https://pharmaphorum.com/news/biosig-cleared-to-test-merimepodib-plus-remdesivir-in-covid-19/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Patient Engagement Event - a real world snapshot, beyond the talk

Patient Engagement Event - a real world snapshot, beyond the talk

Most popular

Most Viewed

Bayer tops pharma rankings for diversity, inclusivity
Sanofi looks east with €300m Innovent cancer alliance
Sosei Heptares banks $30m milestone in Neurocrine Bio alliance
Gilead snaps up MiroBio and its checkpoint agonists for $405m
Amgen splashes out on ChemoCentryx and its blockbuster hopeful

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise
pharmaphorum connect

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com